201 related articles for article (PubMed ID: 37352885)
1. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.
Thakar MS; Logan BR; Puck JM; Dunn EA; Buckley RH; Cowan MJ; O'Reilly RJ; Kapoor N; Satter LF; Pai SY; Heimall J; Chandra S; Ebens CL; Chellapandian D; Williams O; Burroughs LM; Saldana BD; Rayes A; Madden LM; Chandrakasan S; Bednarski JJ; DeSantes KB; Cuvelier GDE; Teira P; Gillio AP; Eissa H; Knutsen AP; Goldman FD; Aquino VM; Shereck EB; Moore TB; Caywood EH; Lugt MTV; Rozmus J; Broglie L; Yu LC; Shah AJ; Andolina JR; Liu X; Parrott RE; Dara J; Prockop S; Martinez CA; Kapadia M; Jyonouchi SC; Sullivan KE; Bleesing JJ; Chaudhury S; Petrovic A; Keller MD; Quigg TC; Parikh S; Shenoy S; Seroogy C; Rubin T; Decaluwe H; Routes JM; Torgerson TR; Leiding JW; Pulsipher MA; Kohn DB; Griffith LM; Haddad E; Dvorak CC; Notarangelo LD
Lancet; 2023 Jul; 402(10396):129-140. PubMed ID: 37352885
[TBL] [Abstract][Full Text] [Related]
2. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.
Heimall J; Logan BR; Cowan MJ; Notarangelo LD; Griffith LM; Puck JM; Kohn DB; Pulsipher MA; Parikh S; Martinez C; Kapoor N; O'Reilly R; Boyer M; Pai SY; Goldman F; Burroughs L; Chandra S; Kletzel M; Thakar M; Connelly J; Cuvelier G; Davila Saldana BJ; Shereck E; Knutsen A; Sullivan KE; DeSantes K; Gillio A; Haddad E; Petrovic A; Quigg T; Smith AR; Stenger E; Yin Z; Shearer WT; Fleisher T; Buckley RH; Dvorak CC
Blood; 2017 Dec; 130(25):2718-2727. PubMed ID: 29021228
[TBL] [Abstract][Full Text] [Related]
3. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ
Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510
[TBL] [Abstract][Full Text] [Related]
4. Primary Immune Deficiency Treatment Consortium (PIDTC) report.
Griffith LM; Cowan MJ; Notarangelo LD; Kohn DB; Puck JM; Pai SY; Ballard B; Bauer SC; Bleesing JJ; Boyle M; Brower A; Buckley RH; van der Burg M; Burroughs LM; Candotti F; Cant AJ; Chatila T; Cunningham-Rundles C; Dinauer MC; Dvorak CC; Filipovich AH; Fleisher TA; Bobby Gaspar H; Gungor T; Haddad E; Hovermale E; Huang F; Hurley A; Hurley M; Iyengar S; Kang EM; Logan BR; Long-Boyle JR; Malech HL; McGhee SA; Modell F; Modell V; Ochs HD; O'Reilly RJ; Parkman R; Rawlings DJ; Routes JM; Shearer WT; Small TN; Smith H; Sullivan KE; Szabolcs P; Thrasher A; Torgerson TR; Veys P; Weinberg K; Zuniga-Pflucker JC;
J Allergy Clin Immunol; 2014 Feb; 133(2):335-47. PubMed ID: 24139498
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic Cell Transplantation for Severe Combined Immunodeficiency Patients: a Japanese Retrospective Study.
Miyamoto S; Umeda K; Kurata M; Nishimura A; Yanagimachi M; Ishimura M; Sato M; Shigemura T; Kato M; Sasahara Y; Iguchi A; Koike T; Takahashi Y; Kajiwara M; Inoue M; Hashii Y; Yabe H; Kato K; Atsuta Y; Imai K; Morio T
J Clin Immunol; 2021 Nov; 41(8):1865-1877. PubMed ID: 34448087
[TBL] [Abstract][Full Text] [Related]
6. Long term outcomes of severe combined immunodeficiency: therapy implications.
Heimall J; Cowan MJ
Expert Rev Clin Immunol; 2017 Nov; 13(11):1029-1040. PubMed ID: 28918671
[TBL] [Abstract][Full Text] [Related]
7. Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers.
Dorsey MJ; Wright NAM; Chaimowitz NS; Dávila Saldaña BJ; Miller H; Keller MD; Thakar MS; Shah AJ; Abu-Arja R; Andolina J; Aquino V; Barnum JL; Bednarski JJ; Bhatia M; Bonilla FA; Butte MJ; Bunin NJ; Chandra S; Chaudhury S; Chen K; Chong H; Cuvelier GDE; Dalal J; DeFelice ML; DeSantes KB; Forbes LR; Gillio A; Goldman F; Joshi AY; Kapoor N; Knutsen AP; Kobrynski L; Lieberman JA; Leiding JW; Oshrine B; Patel KP; Prockop S; Quigg TC; Quinones R; Schultz KR; Seroogy C; Shyr D; Siegel S; Smith AR; Torgerson TR; Vander Lugt MT; Yu LC; Cowan MJ; Buckley RH; Dvorak CC; Griffith LM; Haddad E; Kohn DB; Logan B; Notarangelo LD; Pai SY; Puck J; Pulsipher MA; Heimall J
J Clin Immunol; 2021 Jan; 41(1):38-50. PubMed ID: 33006109
[TBL] [Abstract][Full Text] [Related]
8. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.
Haddad E; Logan BR; Griffith LM; Buckley RH; Parrott RE; Prockop SE; Small TN; Chaisson J; Dvorak CC; Murnane M; Kapoor N; Abdel-Azim H; Hanson IC; Martinez C; Bleesing JJH; Chandra S; Smith AR; Cavanaugh ME; Jyonouchi S; Sullivan KE; Burroughs L; Skoda-Smith S; Haight AE; Tumlin AG; Quigg TC; Taylor C; Dávila Saldaña BJ; Keller MD; Seroogy CM; Desantes KB; Petrovic A; Leiding JW; Shyr DC; Decaluwe H; Teira P; Gillio AP; Knutsen AP; Moore TB; Kletzel M; Craddock JA; Aquino V; Davis JH; Yu LC; Cuvelier GDE; Bednarski JJ; Goldman FD; Kang EM; Shereck E; Porteus MH; Connelly JA; Fleisher TA; Malech HL; Shearer WT; Szabolcs P; Thakar MS; Vander Lugt MT; Heimall J; Yin Z; Pulsipher MA; Pai SY; Kohn DB; Puck JM; Cowan MJ; O'Reilly RJ; Notarangelo LD
Blood; 2018 Oct; 132(17):1737-1749. PubMed ID: 30154114
[TBL] [Abstract][Full Text] [Related]
9. Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC.
Cuvelier GDE; Logan BR; Prockop SE; Buckley RH; Kuo CY; Griffith LM; Liu X; Yip A; Hershfield MS; Ayoub PG; Moore TB; Dorsey MJ; O'Reilly RJ; Kapoor N; Pai SY; Kapadia M; Ebens CL; Forbes Satter LR; Burroughs LM; Petrovic A; Chellapandian D; Heimall J; Shyr DC; Rayes A; Bednarski JJ; Chandra S; Chandrakasan S; Gillio AP; Madden L; Quigg TC; Caywood EH; Dávila Saldaña BJ; DeSantes K; Eissa H; Goldman FD; Rozmus J; Shah AJ; Vander Lugt MT; Thakar MS; Parrott RE; Martinez C; Leiding JW; Torgerson TR; Pulsipher MA; Notarangelo LD; Cowan MJ; Dvorak CC; Haddad E; Puck JM; Kohn DB
Blood; 2022 Aug; 140(7):685-705. PubMed ID: 35671392
[TBL] [Abstract][Full Text] [Related]
10. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901.
Dvorak CC; Cowan MJ; Logan BR; Notarangelo LD; Griffith LM; Puck JM; Kohn DB; Shearer WT; O'Reilly RJ; Fleisher TA; Pai SY; Hanson IC; Pulsipher MA; Fuleihan R; Filipovich A; Goldman F; Kapoor N; Small T; Smith A; Chan KW; Cuvelier G; Heimall J; Knutsen A; Loechelt B; Moore T; Buckley RH
J Clin Immunol; 2013 Oct; 33(7):1156-64. PubMed ID: 23818196
[TBL] [Abstract][Full Text] [Related]
11. Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening.
de Pagter AP; Bredius RG; Kuijpers TW; Tramper J; van der Burg M; van Montfrans J; Driessen GJ;
Eur J Pediatr; 2015 Sep; 174(9):1183-8. PubMed ID: 25875249
[TBL] [Abstract][Full Text] [Related]
12. Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study.
Eissa H; Thakar MS; Shah AJ; Logan BR; Griffith LM; Dong H; Parrott RE; O'Reilly RJ; Dara J; Kapoor N; Forbes Satter L; Chandra S; Kapadia M; Chandrakasan S; Knutsen A; Jyonouchi SC; Molinari L; Rayes A; Ebens CL; Teira P; Dávila Saldaña BJ; Burroughs LM; Chaudhury S; Chellapandian D; Gillio AP; Goldman F; Malech HL; DeSantes K; Cuvelier GDE; Rozmus J; Quinones R; Yu LC; Broglie L; Aquino V; Shereck E; Moore TB; Vander Lugt MT; Mousallem TI; Oved JH; Dorsey M; Abdel-Azim H; Martinez C; Bleesing JH; Prockop S; Kohn DB; Bednarski JJ; Leiding J; Marsh RA; Torgerson T; Notarangelo LD; Pai SY; Pulsipher MA; Puck JM; Dvorak CC; Haddad E; Buckley RH; Cowan MJ; Heimall J
J Allergy Clin Immunol; 2024 Jan; 153(1):287-296. PubMed ID: 37793572
[TBL] [Abstract][Full Text] [Related]
13. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Transplantation outcomes for severe combined immunodeficiency, 2000-2009.
Pai SY; Logan BR; Griffith LM; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Hanson IC; Filipovich AH; Jyonouchi S; Sullivan KE; Small TN; Burroughs L; Skoda-Smith S; Haight AE; Grizzle A; Pulsipher MA; Chan KW; Fuleihan RL; Haddad E; Loechelt B; Aquino VM; Gillio A; Davis J; Knutsen A; Smith AR; Moore TB; Schroeder ML; Goldman FD; Connelly JA; Porteus MH; Xiang Q; Shearer WT; Fleisher TA; Kohn DB; Puck JM; Notarangelo LD; Cowan MJ; O'Reilly RJ
N Engl J Med; 2014 Jul; 371(5):434-46. PubMed ID: 25075835
[TBL] [Abstract][Full Text] [Related]
16. Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.
Guru Murthy GS; Kim S; Hu ZH; Estrada-Merly N; Abid MB; Aljurf M; Bacher U; Badawy SM; Beitinjaneh A; Bredeson C; Cahn JY; Cerny J; Diaz Perez MA; Farhadfar N; Gale RP; Ganguly S; Gergis U; Hildebrandt GC; Grunwald MR; Hashmi S; Hossain NM; Kalaycio M; Kamble RT; Kharfan-Dabaja MA; Hamilton BK; Lazarus HM; Liesveld J; Litzow M; Marks DI; Murthy HS; Nathan S; Nazha A; Nishihori T; Patel SS; Pawarode A; Rizzieri D; Savani B; Seo S; Solh M; Ustun C; van der Poel M; Verdonck LF; Vij R; Wirk B; Oran B; Nakamura R; Scott B; Saber W
JAMA Oncol; 2022 Mar; 8(3):404-411. PubMed ID: 35024768
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic Cell Transplantation for Inborn Errors of Immunity Other than Severe Combined Immunodeficiency in Japan: Retrospective Analysis for 1985-2016.
Miyamoto S; Umeda K; Kurata M; Yanagimachi M; Iguchi A; Sasahara Y; Okada K; Koike T; Tanoshima R; Ishimura M; Yamada M; Sato M; Takahashi Y; Kajiwara M; Kawaguchi H; Inoue M; Hashii Y; Yabe H; Kato K; Atsuta Y; Imai K; Morio T
J Clin Immunol; 2022 Apr; 42(3):529-545. PubMed ID: 34981329
[TBL] [Abstract][Full Text] [Related]
18. Severe combined immunodeficiency (SCID): from molecular basis to clinical management.
Sponzilli I; Notarangelo LD
Acta Biomed; 2011 Apr; 82(1):5-13. PubMed ID: 22069950
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic cell transplantation for treatment of primary immune deficiencies.
Burroughs L; Woolfrey A
Cell Ther Transplant; 2010 Aug; 2(8):. PubMed ID: 21152385
[TBL] [Abstract][Full Text] [Related]
20. The case for severe combined immunodeficiency (SCID) and T cell lymphopenia newborn screening: saving lives…one at a time.
Quinn J; Orange JS; Modell V; Modell F
Immunol Res; 2020 Feb; 68(1):48-53. PubMed ID: 32128663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
